Category Archives: Cell Therapy

Knee arthritis 2.5 years after stem cell therapy by Harry Adelson, N.D. Janet discusses her outcome three and a half years after bone marrow stem cell therapy by Dr Harry Adelson for her arthritic knees http://www.docereclinics.com. By: Harry Adelson, N.D. … Continue reading →

TUESDAY, Oct. 14, 2014 (HealthDay News) -- A new study is the first to show the long-term safety of embryonic stem cell transplants to treat human disease. The research involved 18 people who received the transplants to treat forms of macular degeneration, a leading cause of vision loss. The transplants, which restored some sight in more than half of the patients, appeared safe up to three years after the procedure. The study, funded by a U.S.-based company called Advanced Cell Technology, was published Oct. 14 in The Lancet. "Embryonic stem cells have the potential to become any cell type in the body, but transplantation has been complicated by problems," lead author Dr. Robert Lanza, chief scientific officer at Advanced Cell Technology, said in a journal news release. Those problems include the rejection of the transplanted cells by the patient's immune system, as well as the danger that the cells might spur certain types of cancers called teratomas. A teratoma is a type of cancer that occurs when stem cells develop into multiple types of cells and form incompatible tissues that can include teeth and hair. As Lanza explained, because of these issues, scientists interested in embryonic stem cell therapy have … Continue reading →

By C. Rajan, contributing writer The U.S. FDA has just granted BrainStorm Cell Therapeutics novel stem cell therapy, NurOwn, Fast Track status for the treatment of amyotrophic lateral sclerosis (ALS), the company announced via press release. "We are pleased that the FDA has granted Fast Track status for NurOwn as this will allow us greater and more frequent dialogue with the Agency as we continue the development of this ground-breaking cell therapy for the treatment of ALS," said Tony Fiorino, MD, PhD, CEO of BrainStorm. "We expect Fast Track designation, which recognizes the potential of NurOwn as to address an unmet medical need in ALS, to help speed and improve our development program." Israeli biotech company BrainStorm is developing novel adult stem cell technologies for neurodegenerative diseases, such as ALS. The company licensed the exclusive rights to the NurOwn technology from Ramot, the technology transfer company of Tel Aviv University. NurOwn is a personalized stem cell product made from autologous mesenchymal stem cells. These adult stem cells are obtained from the patients bone marrow and are induced to secrete neurotrophic factors, which are growth factors that can stimulate the survival and maintenance of neurons that degenerate in neurologic disorders. NurOwn … Continue reading →

By Richard M. Cohen image courtesy Richard Cohen I am one of twenty struggling every day with multiple sclerosis to be included in an innovative, phase one stem cell clinical trial at the Tisch MS Research Center of New York. Now theres a mouthful. Please let me explain. Many of us read tidbits about cell therapy and think it simply is space-age medicine that will be launched in the future. In fact, we are at the starting line now, and the race has begun. A phase one trial tests safety. The group is small, and all are treated with the real thing. No placebos, sugar pills. The trial tests autologous cells, which mean our own. That eliminates rejection and alters risk. No new medical procedure comes risk-free, but the dangers are minimal. The stem cells are pulled from bone marrow harvested from our breast bones. Sounds hideous. It is not. In this trial, the stem cells are infused directly into the spinal column. Nope. Not painful at all. Then we watch and wait. Results, if there are to be any, can take many months to show themselves. This particular procedure has never been used before. I was the first in … Continue reading →

Learn How Stem Cell Therapy Is Being Used Right Here in North Texas http://www.innovationsstemcellcenter.com Call: 214.420.7970 Facebook: https://www.facebook.com/innovationsmedical Twitter: https://twitter.com/dallasdrj Instagram: http://instagram.com/drbilljo... By: dallasdrj … Continue reading →

Can brain damage caused during birth be ever reversed? Is it possible to repair the damaged brain tissues among children, who suffer from Cerebral Palsy (CP)? So far, the treatment option for CP is to manage the symptoms of the ailment. However, in recent times, scientists and researchers worldwide have started to explore stem cell therapy as a potential treatment option for CP patients. Can stem cells reverse the brain damage, which is the sole cause for CP among children? Our research on over 100 CP patients and stem cell therapy has been very encouraging. The patients, who underwent stem cell therapy, have displayed huge improvement in CP symptoms, says Professor and Head of Neurosurgery, LTM Medical College, Mumbai, Alok Sharma. The neurosurgeon, who is taking part in an international conference on CP in Hyderabad this weekend, said that doctors are not concentrating on treating the brain damage. The current treatment options available to help patients are only to mange symptoms and nobody tries to repair the underlying damage to the brain tissue. Therefore, developing a standard therapeutic approach for CP through stem cells is the need of the hour, he said. The results from the stem cell therapy on … Continue reading →

10.10.2014 - (idw) Fraunhofer-Gesellschaft From 9-10 October 2014 around 200 scientists met at the Leipzig Fraunhofer Institute for Cell Therapy and Immunology for the ninth Fraunhofer Life Science Symposium. Held every two years, this year the event focused on the theme "Medicinal Cell Products and Stem Cells for Medicinal Applications". In recent years biomedical research has revealed numerous promising new approaches for the prevention and treatment of serious illnesses. The issue of stem cells plays a key role in this. With the symposium the Fraunhofer IZI offers international scientists a platform on which they can discuss the latest developments in this field. The scientific program encompasses three major subject areas: production, manufacture and application. In the first section a paper presented by Sarah Ferber (Centre for Stem Cells, Regenerative Medicine and Tissue Engineering, Sheba Medical Center, Tel Hashomer, Israel) was one major point of interest: "Reprogramming the endocrine pancreas; autologous cell replacement therapy for diabetic patients". She spoke about the possibilities for transforming liver cells into insulin-producing cells. In the future this method could possibly be used to help patients with type 1 diabetes, where the misdirected immune system destroys the body's own insulin-producing beta cells of the pancreas. The … Continue reading →

ViaCytes chief scientific officer, explains beat cell encapsulation JDRF research partner ViaCyte is developing an encapsulated cell therapy for treatment of type 1 diabetes. The company has filed an application with the U.S. Food and Drug Administration to... By: JDRF … Continue reading →

Researchers at Cincinnati Childrens Hospital Medical Center have discovered a new gene and cell therapy that could treat a rare lung disease in children. In the study, published in the journal Nature, researchers found that transplanting pulmonary macrophages immune cells into the lungs of mice corrected hereditary pulmonary alveolar proteinosis (hPAP). The lung disease is caused by a build-up of surfactant, an oily substance in the air sacs of the lungs, which results in reduced lung function and eventually failure. The condition is the opposite of a common condition in premature babies, whose lungs are at a higher risk of collapsing because their air sacs will not stay open. Children with hPAP, on the other hand, have such high levels of surfactants that the childrens air sacs overinflate, and they drown internally as a result. Between 2,000 and 3,000 children in the U.S. have hPAP, senior study author Bruce Trapnell, a physician in the division of neonatology and pulmonary biology at Cincinnati Children's Hospital Medical Center, told FoxNews.com. The only available therapy for the rare disease whole-lung lavage is a difficult procedure thats invasive, requires anesthesia and involves mechanical ventilation, Trapnell said. For the surgery, doctors must attach a breathing … Continue reading →

T-cell Tuesday T-cell Therapy infusion day. By: Amanda Jensen … Continue reading →